Methotrexate Sodium Injection
Fresenius Kabi USA, LLC · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 03/13/2023
- Package NDC
- 63323-122-50
- Generic name
- Methotrexate Sodium Injection
- Contact info
- 888-386-1300
- Availability
- Available
- Related info
- Check wholesaler for inventory
- Update date
- 11/03/2026
- Dosage form
- Injection
- Presentation
- Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50)
- Company name
- Fresenius Kabi USA, LLC
- Status
- Current
- Therapeutic category
- Rheumatology, Oncology
- Harmonized identifiers (openFDA)
- Application number
- ANDA040266
- Brand name
- METHOTREXATE
- Generic name
- METHOTREXATE SODIUM
- Manufacturer name
- Fresenius Kabi USA, LLC
- Product NDC
- 63323-122
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRA-ARTERIAL, INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS
- Substance name
- METHOTREXATE SODIUM
- RxCUI
- 311625
- SPL ID
- 3d21237a-ef53-4592-bf06-0c739696203d
- SPL set ID
- ec476b11-0b3c-4139-b1eb-a3daa76bc271
- Package NDC
- 63323-122-50
- UNII
- 3IG1E710ZN
